Cambridge Cancer Genomics
DefunctYC S17Cambridge, GB · Founded 2015 · 25 employees · 4 known investors
CCG.ai develops software that uses clinical and genomic data to help oncologists select appropriate cancer treatments for individual patients, with a focus on identifying predictive biomarkers linked to treatment response.
Founders & leadership· Y Combinator alumni (S17)
Cambridge Cancer Genomics was founded in 2015 by John Cassidy, Nirmesh Patel, and Evaline Tsai.
JC
NP
Nirmesh PatelinFounder/Chief Scientific OfficerNirmesh Patel is founder and Chief Scientific Officer of Cambridge Cancer Genomics, which develops software using clinical and genomic data to help oncologists select cancer treatments tailored to individual patients.
Investors · 4
In the news
Frequently asked questions
- What does Cambridge Cancer Genomics do?
- CCG.ai develops software that uses clinical and genomic data to help oncologists select appropriate cancer treatments for individual patients, with a focus on identifying predictive biomarkers linked to treatment response.
- Who founded Cambridge Cancer Genomics?
- Cambridge Cancer Genomics was founded by John Cassidy, Nirmesh Patel, Evaline Tsai in 2015.
- Who are Cambridge Cancer Genomics's investors?
- Cambridge Cancer Genomics's investors include Amplify Partners, FundersClub, Pi Campus, Y Combinator.
- Where is Cambridge Cancer Genomics headquartered?
- Cambridge Cancer Genomics is headquartered in Cambridge, GB.